{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:23:37Z","timestamp":1788384217792,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303157"],"award-info":[{"award-number":["82303157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M734041"],"award-info":[{"award-number":["2023M734041"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230441"],"award-info":[{"award-number":["BX20230441"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Science and Technology Research Program of Henan Province","award":["LHGJ20190025"],"award-info":[{"award-number":["LHGJ20190025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-024-01910-w","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T22:01:51Z","timestamp":1730930511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["PTPN20 promotes metastasis through activating NF-\u03baB signaling in triple-negative breast cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoxiao","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hequn","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueke","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"issue":"6","key":"1910_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. <ArticleTitle Language=\u201cEn\u201d>Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"4","key":"1910_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cncr.23243","volume":"112","author":"M Brown","year":"2008","unstructured":"Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999\u20132004. Cancer. 2008;112(4):737\u201347.","journal-title":"Cancer"},{"issue":"2","key":"1910_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019;9(2):176\u201398.","journal-title":"Cancer Discov"},{"issue":"21","key":"1910_CR4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492\u2013502.","journal-title":"JAMA"},{"issue":"10286","key":"1910_CR5","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet (London England). 2021;397(10286):1750\u201369.","journal-title":"Lancet (London England)"},{"issue":"1","key":"1910_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","volume":"9","author":"F Kassam","year":"2009","unstructured":"Kassam F, Enright K, Dent R, Dranitsaris G, Myers J, Flynn C, et al. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design. Clin Breast Cancer. 2009;9(1):29\u201333.","journal-title":"Clin Breast Cancer"},{"issue":"20","key":"1910_CR7","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363(20):1938\u201348.","journal-title":"N Engl J Med"},{"issue":"1","key":"1910_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin L, Duan JJ, Bian XW, Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast cancer research: BCR. 2020;22(1):61.","journal-title":"Breast cancer research: BCR"},{"issue":"1","key":"1910_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","volume":"15","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Merkher Y, Chen L, Liu N, Leonov S, et al. Recent advances in therapeutic strategies for triple-negative breast cancer. J Hematol Oncol. 2022;15(1):121.","journal-title":"J Hematol Oncol"},{"issue":"5","key":"1910_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576\u201390.","journal-title":"Cancer Cell"},{"issue":"630","key":"1910_CR11","doi-asserted-by":"publisher","first-page":"eabf5473","DOI":"10.1126\/scitranslmed.abf5473","volume":"14","author":"M Zhang","year":"2022","unstructured":"Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, et al. CECR2 drives breast cancer metastasis by promoting NF-\u03baB signaling and macrophage-mediated immune suppression. Sci Transl Med. 2022;14(630):eabf5473.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1910_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm1519","volume":"13","author":"BK Park","year":"2007","unstructured":"Park BK, Zhang H, Zeng Q, Dai J, Keller ET, Giordano T, et al. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat Med. 2007;13(1):62\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"1910_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2009.137","volume":"20","author":"F Wan","year":"2010","unstructured":"Wan F, Lenardo MJ. The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives. Cell Res. 2010;20(1):24\u201333.","journal-title":"Cell Res"},{"issue":"6","key":"1910_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/0092-8674(86)90807-X","volume":"47","author":"R Sen","year":"1986","unstructured":"Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47(6):921\u20138.","journal-title":"Cell"},{"issue":"7","key":"1910_CR15","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1002\/j.1460-2075.1991.tb07707.x","volume":"10","author":"MB Urban","year":"1991","unstructured":"Urban MB, Schreck R, Baeuerle PA. NF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 1991;10(7):1817\u201325.","journal-title":"EMBO J"},{"issue":"1","key":"1910_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/embr.201337983","volume":"15","author":"M Hinz","year":"2014","unstructured":"Hinz M, Scheidereit C. The I\u03baB kinase complex in NF-\u03baB regulation and beyond. EMBO Rep. 2014;15(1):46\u201361.","journal-title":"EMBO Rep"},{"issue":"1","key":"1910_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu H, Lin L, Zhang Z, Zhang H. Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study. Signal Transduct Target therapy. 2020;5(1):209.","journal-title":"Signal Transduct Target therapy"},{"issue":"12","key":"1910_CR18","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1038\/sj.emboj.7600244","volume":"23","author":"F Yeung","year":"2004","unstructured":"Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004;23(12):2369\u201380.","journal-title":"EMBO J"},{"issue":"357","key":"1910_CR19","first-page":"re13","volume":"2006","author":"H H\u00e4cker","year":"2006","unstructured":"H\u00e4cker H, Karin M. Regulation and function of IKK and IKK-related kinases. Science\u2019s STKE: signal Transduct Knowl Environ. 2006;2006(357):re13.","journal-title":"Science\u2019s STKE: signal Transduct Knowl Environ"},{"issue":"41","key":"1910_CR20","doi-asserted-by":"publisher","first-page":"14635","DOI":"10.1073\/pnas.0507342102","volume":"102","author":"E Jacque","year":"2005","unstructured":"Jacque E, Tchenio T, Piton G, Romeo PH, Baud V. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci USA. 2005;102(41):14635\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1910_CR21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S1097-2765(03)00490-8","volume":"12","author":"A Ryo","year":"2003","unstructured":"Ryo A, Suizu F, Yoshida Y, Perrem K, Liou YC, Wulf G, et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65\/RelA. Mol Cell. 2003;12(6):1413\u201326.","journal-title":"Mol Cell"},{"issue":"5838","key":"1910_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1126\/science.1142953","volume":"317","author":"RJ Carmody","year":"2007","unstructured":"Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH. Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Sci (New York NY). 2007;317(5838):675\u20138.","journal-title":"Sci (New York NY)"},{"issue":"7664","key":"1910_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature23270","volume":"547","author":"RT Manguso","year":"2017","unstructured":"Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, et al. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017;547(7664):413\u20138.","journal-title":"Nature"},{"issue":"8","key":"1910_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/1440-1681.13098","volume":"46","author":"J Cai","year":"2019","unstructured":"Cai J, Huang S, Yi Y, Bao S. Downregulation of PTPN18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer. Clin Exp Pharmacol Physiol. 2019;46(8):734\u201342.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1910_CR25","doi-asserted-by":"publisher","first-page":"972906","DOI":"10.3389\/fonc.2022.972906","volume":"12","author":"X Tang","year":"2022","unstructured":"Tang X, Qi C, Zhou H, Liu Y. Critical roles of PTPN family members regulated by non-coding RNAs in tumorigenesis and immunotherapy. Front Oncol. 2022;12:972906.","journal-title":"Front Oncol"},{"issue":"12","key":"1910_CR26","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1016\/j.celrep.2016.08.048","volume":"16","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Christin JR, Wang C, Ge K, Oktay MH, Guo W. Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation. Cell Rep. 2016;16(12):3146\u201356.","journal-title":"Cell Rep"},{"key":"1910_CR27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12935-020-01315-7","volume":"20","author":"J Chen","year":"2020","unstructured":"Chen J, Zhao X, Yuan Y, Jing JJ. The expression patterns and the diagnostic\/prognostic roles of PTPN family members in digestive tract cancers. Cancer Cell Int. 2020;20:238.","journal-title":"Cancer Cell Int"},{"key":"1910_CR28","doi-asserted-by":"publisher","first-page":"1212692","DOI":"10.3389\/fimmu.2023.1212692","volume":"14","author":"L Ma","year":"2023","unstructured":"Ma L, Liu Y, Wang Y, Yang J, Lu J, Feng H, et al. Identification of PTPN20 as an innate immunity-related gene in gastric cancer with Helicobacter pylori infection. Front Immunol. 2023;14:1212692.","journal-title":"Front Immunol"},{"issue":"1","key":"1910_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12987-022-00341-z","volume":"19","author":"H Xu","year":"2022","unstructured":"Xu H, Miyajima M, Nakajima M, Ogino I, Kawamura K, Akiba C, et al. Ptpn20 deletion in H-Tx rats enhances phosphorylation of the NKCC1 cotransporter in the choroid plexus: an evidence of genetic risk for hydrocephalus in an experimental study. Fluids barriers CNS. 2022;19(1):39.","journal-title":"Fluids barriers CNS"},{"issue":"1","key":"1910_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-015-0131-9","volume":"7","author":"LH Saal","year":"2015","unstructured":"Saal LH, Vallon-Christersson J, H\u00e4kkinen J, Hegardt C, Grabau D, Winter C, et al. The Sweden Cancerome Analysis Network - Breast (SCAN-B) Initiative: a large-scale multicenter infrastructure towards implementation of breast cancer genomic analyses in the clinical routine. Genome Med. 2015;7(1):20.","journal-title":"Genome Med"},{"key":"1910_CR31","doi-asserted-by":"crossref","unstructured":"Brueffer C, Vallon-Christersson J, Grabau D, Ehinger A, H\u00e4kkinen J, Hegardt C et al. Clinical Value of RNA Sequencing-Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network-Breast Initiative. JCO precision Oncol 2018;2.","DOI":"10.1200\/PO.17.00135"},{"issue":"7","key":"1910_CR32","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Investig. 2011;121(7):2750\u201367.","journal-title":"J Clin Investig"},{"issue":"22","key":"1910_CR33","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41388-024-03025-0","volume":"43","author":"L Bottoni","year":"2024","unstructured":"Bottoni L, Minetti A, Realini G, Pio E, Giustarini D, Rossi R, et al. NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells. Oncogene. 2024;43(22):1701\u201313.","journal-title":"Oncogene"},{"key":"1910_CR34","doi-asserted-by":"publisher","first-page":"102672","DOI":"10.1016\/j.ctrv.2023.102672","volume":"123","author":"A Dri","year":"2024","unstructured":"Dri A, Arpino G, Bianchini G, Curigliano G, Danesi R, De Laurentiis M, et al. Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs). Cancer Treat Rev. 2024;123:102672.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"1910_CR35","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.drudis.2019.02.012","volume":"24","author":"M Vojtek","year":"2019","unstructured":"Vojtek M, Marques MPM, Ferreira I, Mota-Filipe H, Diniz C. Anticancer activity of palladium-based complexes against triple-negative breast cancer. Drug Discovery Today. 2019;24(4):1044\u201358.","journal-title":"Drug Discovery Today"},{"issue":"11","key":"1910_CR36","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat reviews Clin Oncol. 2016;13(11):674\u201390.","journal-title":"Nat reviews Clin Oncol"},{"key":"1910_CR37","doi-asserted-by":"publisher","first-page":"154962","DOI":"10.1016\/j.prp.2023.154962","volume":"253","author":"S Mohan","year":"2024","unstructured":"Mohan S, Hakami MA, Dailah HG, Khalid A, Najmi A, Zoghebi K, et al. From inflammation to metastasis: The central role of miR-155 in modulating NF-\u03baB in cancer. Pathol Res Pract. 2024;253:154962.","journal-title":"Pathol Res Pract"},{"issue":"10","key":"1910_CR38","doi-asserted-by":"publisher","first-page":"6175","DOI":"10.1074\/jbc.M508045200","volume":"281","author":"I Mattioli","year":"2006","unstructured":"Mattioli I, Geng H, Sebald A, Hodel M, Bucher C, Kracht M, et al. Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. J Biol Chem. 2006;281(10):6175\u201383.","journal-title":"J Biol Chem"},{"key":"1910_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jim.2015.03.018","volume":"423","author":"O Maguire","year":"2015","unstructured":"Maguire O, O\u2019Loughlin K, Minderman H. Simultaneous assessment of NF-\u03baB\/p65 phosphorylation and nuclear localization using imaging flow cytometry. J Immunol Methods. 2015;423:3\u201311.","journal-title":"J Immunol Methods"},{"key":"1910_CR40","doi-asserted-by":"crossref","unstructured":"Chien CS, Li JY, Chien Y, Wang ML, Yarmishyn AA, Tsai PH et al. METTL3-dependent N(6)-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. Proc Natl Acad Sci USA 2021;118(7).","DOI":"10.1073\/pnas.2025070118"},{"issue":"1","key":"1910_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10549-012-2053-1","volume":"135","author":"CW Yde","year":"2012","unstructured":"Yde CW, Emdal KB, Guerra B, Lykkesfeldt AE. NF\u03baB signaling is important for growth of antiestrogen resistant breast cancer cells. Breast Cancer Res Treat. 2012;135(1):67\u201378.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1910_CR42","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1165\/rcmb.2012-0047OC","volume":"47","author":"KM Bijli","year":"2012","unstructured":"Bijli KM, Fazal F, Rahman A. Regulation of Rela\/p65 and endothelial cell inflammation by proline-rich tyrosine kinase 2. Am J Respir Cell Mol Biol. 2012;47(5):660\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"48","key":"1910_CR43","doi-asserted-by":"publisher","first-page":"49571","DOI":"10.1074\/jbc.C400442200","volume":"279","author":"H Buss","year":"2004","unstructured":"Buss H, D\u00f6rrie A, Schmitz ML, Frank R, Livingstone M, Resch K, et al. Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. J Biol Chem. 2004;279(48):49571\u20134.","journal-title":"J Biol Chem"},{"issue":"12","key":"1910_CR44","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1096\/fj.05-3736fje","volume":"19","author":"RF Schwabe","year":"2005","unstructured":"Schwabe RF, Sakurai H. IKKbeta phosphorylates p65 at S468 in transactivaton domain 2. FASEB journal: official publication Federation Am Soc Experimental Biology. 2005;19(12):1758\u201360.","journal-title":"FASEB journal: official publication Federation Am Soc Experimental Biology"},{"issue":"6","key":"1910_CR45","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/ni1464","volume":"8","author":"T Tanaka","year":"2007","unstructured":"Tanaka T, Grusby MJ, Kaisho T. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol. 2007;8(6):584\u201391.","journal-title":"Nat Immunol"},{"issue":"Pt 2","key":"1910_CR46","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1042\/BJ20041932","volume":"389","author":"MT Fodero-Tavoletti","year":"2005","unstructured":"Fodero-Tavoletti MT, Hardy MP, Cornell B, Katsis F, Sadek CM, Mitchell CA, et al. Protein tyrosine phosphatase hPTPN20a is targeted to sites of actin polymerization. Biochem J. 2005;389(Pt 2):343\u201354.","journal-title":"Biochem J"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-024-01910-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-024-01910-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T23:02:17Z","timestamp":1730934137000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-024-01910-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1186\/s13058-024-01910-w","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"22 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval (No. B2024-053) and prior patient consents were obtained from the Institutional Research Ethics Committee of Sun Yat-sen University Cancer Center to use the clinical specimens for research purposes. Animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (No. L102042024000K). According to the guidelines (GB\/T35892-2018), the ethics committee specified that the maximal tumor burden is no more than 10% of the body weight of animals and the average diameter is less than 20\u00a0mm. During the experiment, the tumor sizes of the mice complied with the regulations. The study complied with the principles set out in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Correspondence to Hequn Zou, Dongni Shi or Xueke Qian.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Corresponding authors"}}],"article-number":"155"}}